Boutin JA - Search Results

1

Apigenin and Luteolin Regulate Autophagy by Targeting NRH-Quinone Oxidoreductase 2 in Liver Cells.

Janda E, Martino C, Riillo C, Parafati M, Lascala A, Mollace V, Boutin JA. Janda E, et al. Among authors: boutin ja. Antioxidants (Basel). 2021 May 13;10(5):776. doi: 10.3390/antiox10050776. Antioxidants (Basel). 2021. PMID: 34068281 Free PMC article.

2

Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme.

Janda E, Nepveu F, Calamini B, Ferry G, Boutin JA. Janda E, et al. Among authors: boutin ja. Mol Pharmacol. 2020 Nov;98(5):620-633. doi: 10.1124/molpharm.120.000105. Epub 2020 Sep 10. Mol Pharmacol. 2020. PMID: 32913139 Review.

3

S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization.

Boutin JA, Bouillaud F, Janda E, Gacsalyi I, Guillaumet G, Hirsch EC, Kane DA, Nepveu F, Reybier K, Dupuis P, Bertrand M, Chhour M, Le Diguarher T, Antoine M, Brebner K, Da Costa H, Ducrot P, Giganti A, Goswami V, Guedouari H, Michel PP, Patel A, Paysant J, Stojko J, Viaud-Massuard MC, Ferry G. Boutin JA, et al. Mol Pharmacol. 2019 Mar;95(3):269-285. doi: 10.1124/mol.118.114231. Epub 2018 Dec 19. Mol Pharmacol. 2019. PMID: 30567956 Free article.

4

Point-Substitution of Phenylalanine Residues of 26RFa Neuropeptide: A Structure-Activity Relationship Study.

Lefranc B, Alim K, Neveu C, Le Marec O, Dubessy C, Boutin JA, Chuquet J, Vaudry D, Prévost G, Picot M, Vaudry H, Chartrel N, Leprince J. Lefranc B, et al. Among authors: boutin ja. Molecules. 2021 Jul 16;26(14):4312. doi: 10.3390/molecules26144312. Molecules. 2021. PMID: 34299587 Free PMC article.

5

Role of Quinone Reductase 2 in the Antimalarial Properties of Indolone-Type Derivatives.

Cassagnes LE, Rakotoarivelo N, Sirigu S, Pério P, Najahi E, Chavas LM, Thompson A, Gayon R, Ferry G, Boutin JA, Valentin A, Reybier K, Nepveu F. Cassagnes LE, et al. Among authors: boutin ja. Molecules. 2017 Jan 30;22(2):210. doi: 10.3390/molecules22020210. Molecules. 2017. PMID: 28146103 Free PMC article.

6

NRH:quinone reductase 2: an enzyme of surprises and mysteries.

Vella F, Ferry G, Delagrange P, Boutin JA. Vella F, et al. Among authors: boutin ja. Biochem Pharmacol. 2005 Dec 19;71(1-2):1-12. doi: 10.1016/j.bcp.2005.09.019. Epub 2005 Oct 25. Biochem Pharmacol. 2005. PMID: 16253210 Review.

7

Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.

Mailliet F, Ferry G, Vella F, Berger S, Cogé F, Chomarat P, Mallet C, Guénin SP, Guillaumet G, Viaud-Massuard MC, Yous S, Delagrange P, Boutin JA. Mailliet F, et al. Among authors: boutin ja. Biochem Pharmacol. 2005 Dec 19;71(1-2):74-88. doi: 10.1016/j.bcp.2005.09.030. Epub 2005 Nov 15. Biochem Pharmacol. 2005. PMID: 16293234

8

Is There Sufficient Evidence that the Melatonin Binding Site MT₃ Is Quinone Reductase 2?

Boutin JA, Ferry G. Boutin JA, et al. J Pharmacol Exp Ther. 2019 Jan;368(1):59-65. doi: 10.1124/jpet.118.253260. Epub 2018 Nov 2. J Pharmacol Exp Ther. 2019. PMID: 30389722 Review.

9

Measuring Binding at the Putative Melatonin Receptor MT3.

Legros C, Dupuis P, Ferry G, Boutin JA. Legros C, et al. Among authors: boutin ja. Methods Mol Biol. 2022;2550:283-289. doi: 10.1007/978-1-0716-2593-4_30. Methods Mol Biol. 2022. PMID: 36180699

10

Cloning, Expression, Purification, Crystallization, and X-Ray Structural Determination of the Human NQO2 in Complex with Melatonin.

Calamini B, Ferry G, Boutin JA. Calamini B, et al. Among authors: boutin ja. Methods Mol Biol. 2022;2550:291-304. doi: 10.1007/978-1-0716-2593-4_31. Methods Mol Biol. 2022. PMID: 36180700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page